$2.28T
Total marketcap
$127.37B
Total volume
BTC 49.85%     ETH 15.72%
Dominance

ResMed Inc. RMEA.F Stock

17.5 EUR {{ price }} -1.129948% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
25.74B EUR
LOW - HIGH [24H]
17.5 - 17.5 EUR
VOLUME [24H]
200 EUR
{{ volume }}
P/E Ratio
31.25
Earnings per share
0.56 EUR

ResMed Inc. Price Chart

ResMed Inc. RMEA.F Financial and Trading Overview

ResMed Inc. stock price 17.5 EUR
Previous Close 15.2 EUR
Open 14.9 EUR
Bid 15 EUR x 90000
Ask 15.5 EUR x 90000
Day's Range 14.9 - 14.9 EUR
52 Week Range 14.9 - 23.2 EUR
Volume 300 EUR
Avg. Volume 14 EUR
Market Cap 21.99B EUR
Beta (5Y Monthly) 0.478697
PE Ratio (TTM) 26.14035
EPS (TTM) 0.56 EUR
Forward Dividend & Yield 0.18 (1.15%)
Ex-Dividend Date August 16, 2023
1y Target Est N/A

RMEA.F Valuation Measures

Enterprise Value 10.28B EUR
Trailing P/E 26.14035
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.207705
Price/Book (mrq) 2.122356
Enterprise Value/Revenue 2.435
Enterprise Value/EBITDA 7.957

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.478697
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 23.2 EUR
52 Week Low 14.9 EUR
50-Day Moving Average 18.81 EUR
200-Day Moving Average 19.95 EUR

RMEA.F Share Statistics

Avg. Volume (3 month) 14 EUR
Avg. Daily Volume (10-Days) 30 EUR
Shares Outstanding 1.47B
Float 582.76M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 7.51%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.76
Trailing Annual Dividend Yield 11.57%
5 Year Average Dividend Yield N/A
Payout Ratio 0.289
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2023
Most Recent Quarter (mrq) June 30, 2023
Next Fiscal Year End June 30, 2024

Profitability

Profit Margin 21.25%
Operating Margin (ttm) 27.27%
Gross Margin 56.50%
EBITDA Margin 30.59%

Management Effectiveness

Return on Assets (ttm) 12.15%
Return on Equity (ttm) 23.96%

Income Statement

Revenue (ttm) 4.22B EUR
Revenue Per Share (ttm) 7.19 EUR
Quarterly Revenue Growth (yoy) 22.69%
Gross Profit (ttm) 2.39B EUR
EBITDA 1.29B EUR
Net Income Avi to Common (ttm) 897.56M EUR
Diluted EPS (ttm) 0.57
Quarterly Earnings Growth (yoy) 17.69%

Balance Sheet

Total Cash (mrq) 240.31M EUR
Total Cash Per Share (mrq) 0.41 EUR
Total Debt (mrq) 1.58B EUR
Total Debt/Equity (mrq) 38.26 EUR
Current Ratio (mrq) 3.122
Book Value Per Share (mrq) 7.0205

Cash Flow Statement

Operating Cash Flow (ttm) 693.3M EUR
Levered Free Cash Flow (ttm) 415.36M EUR

Profile of ResMed Inc.

Country Germany
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858-836-5000
Website https://www.resmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 10140

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current RMEA.F stock price?

ResMed Inc. RMEA.F stock price today per share is 17.5 EUR.

How to purchase ResMed Inc. stock?

You can buy RMEA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is RMEA.F.

Which industry does the ResMed Inc. company belong to?

The ResMed Inc. industry is Medical Instruments & Supplies.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 1.47B.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 31.25000000 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 0.56 EUR over the trailing 12 months.

Which sector does the ResMed Inc. company belong to?

The ResMed Inc. sector is Healthcare.